The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype. Navaeiseddighi Z, Schmit T, Wang Z, Ahamed N, et al. Vaccine 2025;54:126983.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Navaeiseddighi Z, Schmit T, Wang Z, Ahamed N, et al. The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype. Vaccine 2025;54:126983.
PMID: 40056805